EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction

Alexander Chen iD, Joshua M Mesfin iD, Nathan C Gianneschi iD, Karen L Christman iD

Advanced Materials · 2024-10 · 36 (43)

DOI: 10.1002/adma.202300603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 29.10.2023. Verfasst von Alexander Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shu Chien-Gene Lay Department of Bioengineering, Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, 9203…. Hauptthemen laut MEDLINE: Myocardial Infarction, Biocompatible Materials. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIBIB NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Each year, nearly 19 million people die of cardiovascular disease with coronary heart disease and myocardial infarction (MI) as the leading cause of the progression of heart failure. Due to the high risk associated with surgical procedures, a variety of minimally invasive therapeutics aimed at tissue repair and regeneration are being developed. While biomaterials delivered via intramyocardial injection have shown promise, there are challenges associated with delivery in acute MI. In contrast, intravascularly injectable biomaterials are a desirable category of therapeutics due to their ability to be delivered immediately post‐MI via less invasive methods. In addition to passive diffusion into the infarct, these biomaterials can be designed to target the molecular and cellular characteristics seen in MI pathophysiology, such as cells and proteins present in the ischemic myocardium, to reduce off‐target localization. These injectable materials can also be stimuli‐responsive through enzymes or chemical imbalances. This review outlines the natural and synthetic biomaterial designs that allow for retention and accumulation within the infarct via intravascular delivery, including intracoronary infusion and intravenous injection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionBiocompatible MaterialsHumansAnimalsRegenerationDrug Delivery Systems

Stichwörter der Autor:innen

cardiac repairinjectable biomaterialsintravascular biomaterialsmyocardial infarction

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Shu Chien-Gene Lay Department of Bioengineering, Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA, 92037, USA.
  • Department of Chemistry and Biomedical Engineering, International Institute for Nanotechnology, Simpson-Querrey Institute, Chemistry of Life Processes Institute, Northwestern University, Evanston, IL, 60208, USA.

ORCID-Profile: Alexander Chen, Joshua M Mesfin, Nathan C Gianneschi, Karen L Christman

Förderung

  • NHLBI NIH HHS
  • NIBIB NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Chen, A., Mesfin, J. M., Gianneschi, N. C., & Christman, K. L. (2024). Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction. Advanced Materials, 36(43). https://doi.org/10.1002/adma.202300603

Vancouver

Chen A, Mesfin JM, Gianneschi NC, Christman KL. Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction. Advanced Materials. 2024;36(43). doi:10.1002/adma.202300603

BibTeX
@article{Chen2024,
  author = {Chen, Alexander and Mesfin, Joshua M and Gianneschi, Nathan C and Christman, Karen L},
  title = {Intravascularly Deliverable Biomaterial Platforms for Tissue Repair and Regeneration Post‐Myocardial Infarction},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {43},
  doi = {10.1002/adma.202300603}
}
Kostenlos starten →